Navigation Links
QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes
Date:3/19/2008

NEW YORK, March 19 /PRNewswire/ -- QED International Associates Inc., administrator for the HealthShares(TM) Indexes, a series of 20 underlying indexes for the HealthShares(TM) Exchange-Traded Funds, today announced the quarterly rebalancing of the Indexes.

The following securities will be added and deleted in the Indexes effective before the opening of trading on NYSE Arca March 24, 2008.

Autoimmune-Inflammation Index (HHA)

Drop

GW Pharmaceuticals, Inc (LSE: GWP.L)

Human Genome Sciences (Nasdaq: HGSI)

Ligand Pharmaceuticals, Inc. (Nasdaq: LGND)

Add

Fornix Biosciences N.V. (Amsterdam: FORBI.AS)

Meda AB (SHSE1: MEDA A)

Mitsubishi Tanabe Pharma Corporation (TSE: 4508)

Cancer Index (HHK)

Drop

Shire PLC (Nasdaq: SHPGY)

Add

Ark Therapeutics Group Plc (LSE: AKT.L)

Cardio Devices Index (HHE)

Drop

Biosphere Medical, Inc. (Nasdaq: BSMD)

Add

Zoll Medical Corp. (Nasdaq: KERX)

Add

Dyanvax Technologies (Nasdaq: DVAX)

Synta Pharmaceuticals Corp. (Nasdaq: SNTA)

Enabling Technologies Index (HHV)

Drop

Hillenbrand Industries (NYSE: HB)

Add

Eurand N.V. (Nasdaq: EURX)

GI/Gender Index (HHU)

Drop

AEterna Zentaris (Nasdaq: AEZS)

King Pharmaceuticals (NYSE: KG)

Nastech Pharmaceutical (Nasdaq: NSTK)

Add

Columbia Laboratories Inc. (Nasdaq: CBRX)

Eisai Co. Ltd. (Tokyo Stock Exchange: 4523)

Mylan, Inc. (NYSE: MYL)

Metabolic-Endocrine Disorders Index (HHM)

Drop

Depomed Inc. (Nasdaq: DEPO)

Emisphere Technologies Inc. (Nasdaq: EMIS)

Flamel Technologies SA ADS (Nasdaq: FLML)

Hospira Inc. (NYSE: HSP)

Human Genome Sciences, Inc. (Nasdaq: HGSI)

Indevus Pharmaceuticals Inc. (Nasdaq: IDEV)

Ipsen Ltd. (Paris: IPN.PR)

Nastech Pharmaceutical Co. (Nasdaq: NSTK)

Nektar Therapeutics (Nasdaq: NKTR)

NicOx S.A. (Paris: NCOX)

OSI Pharmaceuticals Inc. (Nasdaq: OSIP)

ProStrakan Group Plc (LSE: PSK.L)

Solvay S.A. (Brussels: SVYSY)

Add

Altus Pharmaceuticals Inc. (Nasdaq: ALTU)

Amicus Therapeutics, Inc. (Nasdaq: FOLD)

Biodel Inc. (Nasdaq: BIOD)

CombinatoRx Inc. (Nasdaq: CRXX)

GW Pharmaceuticals Plc (LSE: GWP.L)

Incyte Corp. (Nasdaq: INCY)

Orexigen Therapeutics, Inc. (Nasdaq: OREX)

Repros Therapeutics Inc. (Nasdaq: RPRX)

Sangamo BioSciences Inc. (Nasdaq: SGMO)

Sirtris Pharmaceuticals, Inc. (Nasdaq: SIRT)

SuperGen Inc. (Nasdaq: SUPG)

Transition Therapeutics Inc. (Nasdaq: TTHI)

XOMA Ltd. (Nasdaq: XOMA)

Neuroscience Index (HHN)

Drop

Neurochem Inc. (Nasdaq: NRMX)

Add

Caraco Pharmaceutical Laboratories Ltd. (Amex: CPD)

Ophthalmology Index (HHZ)

Drop

Insite Vision Inc. (Amex: ISV)

Add

King Pharmaceuticals (NYSE: KG)

Patient Care Services Index (HHB)

Drop

Fresenius Medical Care (XETRA: FME.DE)

Add

Coventry Health Care Inc. (NYSE: CVH)

The rebalanced Indexes, including the rebalanced Index Shares, are based on the closing prices as of March 14, 2008.

In accordance with the Exemptive Order, a complete list of the constituents reflecting the rebalancing will be posted at http://www.healthsharesinc.com/content/view/53/274/.

About QED International Associates

QED International, based in New York, is a leading financial industry consulting firm specializing in quantitative modeling and the design, development and maintenance of indexes and Exchange Traded Funds. For more information, visit the company's website at http://www.qedinternational.com

Ticker=ZOLL" onClick="var s=s_gi(s_account); var hd1 = document.getElementById('headline'); s.tl(this,'o',getLinkName('Company Sanpshot'));" >ZOLL)

Cardiology Index (HRD)

Drop

Encysive Pharmaceuticals, Inc. (Nasdaq: ENCY)

Human Genome Sciences, Inc (Nasdaq: HGSI)

Vical, Inc (Nasdaq: VICL)

Add

Mitsubishi Tanabe Pharma Corporation (TSE: 4508)

Sangamo BioSciences Inc (Nasdaq: SGMO)

Sciele Pharma, Inc. (Nasdaq: SCRX)

Composite Index (HHQ)

Drop

Advanced Medical Optics, Inc. (NYSE: EYE)

Align Technology Inc. (Nasdaq: ALGN)

Array Biopharma Inc. (Nasdaq: ARRY)

ArthroCare Corp. (Nasdaq: ARTC)

Endo Pharmaceuticals Hldgs. (Nasdaq: ENDP)

Fresenius Medical Care AG (XETRA: FME.DE)

GEDEON RICHTER RT (XETRA: R1G1.DE)

GENMAB A/S (Copenhagen: GEN.CO)

H. LUNDBECK A/S (Copenhagen: LUN.CO)

Human Genome Sciences (Nasdaq: HGSI)

Imclone Systems (Nasdaq: IMCL)

Inverness Medical Innovations (Amex: IMA)

Invitrogen Corp. (Nasdaq: IVGN)

Medarex Inc. (Nasdaq: MEDX)

Medicis Pharmaceutical (NYSE: MRX)

Mentor Corp. (NYSE: MNT)

ONYX Pharmaceuticals Inc. (Nasdaq: ONXX)

PDL BioPharma, Inc. (Nasdaq: PDLI)

Pharmion Corp. (Nasdaq: PHRM)

Progenics Pharmaceuticals Inc. (Nasdaq: PGNX)

Regeneron Pharmaceuticals (Nasdaq: REGN)

Respironics Inc. (Nasdaq: RESP)

Sepracor Inc. (Nasdaq: SEPR)

Theravance Inc. (Nasdaq: THRX)

United Therapeutics Corp. (Nasdaq: UTHR)

Valeant Pharmaceuticals Int'l (NYSE: VRX)

Vertex Pharmaceuticals (Nasdaq: VRTX)

Add

Adolor Corp. (Nasdaq: ADLR)

ALLOS THERAPEUTICS INC. (Nasdaq: ALTH)

Alnylam Pharmaceuticals Inc. (Nasdaq: ALNY)

Alpharma Inc. (NYSE: ALO)

Altus Pharmaceuticals Inc. (Nasdaq: ALTU)

AMAG Pharmaceuticals Inc. (Nasdaq: AMAG)

ANGIOTECH PHARMACEUTICALS (Nasdaq: ANPI)

Ark Therapeutics (LSE: AKT.L)

Bavarian Nordic A/S (Copenhagen: BAVA.CO)

Caraco Pharmaceutical Laboratories Ltd. (Amex: CPD)

Cardiome Pharma Corp. (Nasdaq: CRME)

Coventry Health Care Inc. (NYSE: CVH)

CRUCELL-ADR (Nasdaq: CRXL)

CUBIST PHARMACEUTICALS INC. (Nasdaq: CBST)

Discovery Laboratories Inc. (Nasdaq: DSCO)

Eisai Co. Ltd. (TSE: 4523.T)

Encysive Pharmaceuticals Inc. (Nasdaq: ENCY)

Enzo Biochem Inc. (NYSE: ENZ)

ENZON PHARMACEUTICALS INC. (Nasdaq: ENZN)

Exelixis Inc. (Nasdaq: EXEL)

Flamel Technologies (Nasdaq: FLML)

Illumina Inc. (Nasdaq: ILMN)

Incyte Corporation (Nasdaq: INCY)

Integra LifeSciences Holdings (Nasdaq: IART)

Meda AB (Stockholm: MEDAA.ST)

Mitsubishi Tanabe Pharma (TSE: 4508.T)

Taisho Pharmaceutical Co., Ltd. (TSE: 4535.T)

Dermatology and Wound Index (HRW)

Drop

Shire PLC (ADR) (Nasdaq: SHPGY)

SkyePharma Plc (LSE: SKP.LN)

Add

Standard Chemical & Pharm. Co., Ltd. (TSE: 1720)

Taisho Pharmaceutical Co., Ltd. (TSE: 4535)

Diagnostics Index (HHD)

Drop

CR Bard, Inc. (NYSE: BCR)

IDEXX Laboratories (Nasdaq: IDXX)

Add

Bruker Corporation (Nasdaq: BRKR)

Halozyme Therapeutic (Nasdaq: HALO)

Emerging Cancer Index (HHJ)

Drop

Adventrx Pharmaceuticals, Inc. (Amex: ANX)

Keryx Biopharmaceuticals, Inc. (Nasdaq:

SOURCE QED International Associates Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. PRA International Announces New Office Opening in Mumbai
2. Solcara Helps AstraZeneca Set International Benchmark for Global Media Relations
3. Mirion Technologies to Showcase New Product Offerings for the Nuclear Industry During 10th Annual China International Nuclear Industry Exhibition
4. International Diabetes Federation gives grant to UMDNJ-University Hospital in Newark
5. Chindex International, Inc. Announces Three-For-Two Stock Split
6. Resources Top 400,000 in Hopkins International Information Service
7. Egyptian foot care center recieves International Diabetes Federation grant
8. Project Concern International Receives a US$1 Million Grant From the Starbucks Foundations Ethos Water Fund to Provide Safe Water and Sanitation Services in Tanzania
9. Position Statement Regarding Lt. Gov. Paterson from Tara A. Cortes, Ph.D, RN President and CEO of Lighthouse International
10. Mettler-Toledo International Inc. Announces Webcast of Presentation at Lehman Brothers Global Healthcare Conference
11. Autism Speaks to Celebrate World Autism Awareness Day with Day-Long Series of International Events on April 2
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... ... 09, 2016 , ... "I have gout, and I wanted to treat it ... is meant to relieve gout and pain caused by varicose veins. I drank it ... time. It relieved what VA doctors called the worst sinusitis case they'd seen and ...
(Date:12/9/2016)... ... December 09, 2016 , ... Sober ... anniversary with the grand opening of the Sober College Robert Pfeifer Memorial Learning ... days, December 2-3, and was attended by an overwhelming amount of alumni, family, ...
(Date:12/9/2016)... New York, NY (PRWEB) , ... December 09, 2016 , ... ... that raises awareness for organ transplantation while encouraging readers to sign up as an ... for a lifesaving organ transplant. , An organ donor can save up to ...
(Date:12/9/2016)... (PRWEB) , ... December 09, 2016 , ... ... whiteboard display solutions, proudly announced today that a new solution for Emergency Departments ... fit in the tight space in Emergency Department examination rooms, and with a ...
(Date:12/9/2016)... ... 09, 2016 , ... The Pennsylvania Athletic Trainers’ Society (PATS) ... summer of 2016. The program was made possible by a Pennsylvania Department of ... Health and Human Services Administration. The broadcast, Use Your Head: Properly Managing ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... LONDON , Dec. 8, 2016 ... Summary GlobalData,s new report, "Australia Glaucoma ... market data on the Australia Glaucoma Surgery Devices ... US dollars, volume (in units) and average prices ... The report also provides company shares and ...
(Date:12/8/2016)... , Dec. 8, 2016 KEY FINDINGS ... largest share of the market in 2016 and is ... can be attributed to a large number of surgical ... hold the largest share in the patient temperature management ... such as reducing loss of blood during surgeries, lowering ...
(Date:12/8/2016)... Research and Markets has announced the addition ... Adhesion Type, Application, Usability - Forecast to 2025" report to ... , , ... poised to grow at a CAGR of around 3.2% from 2015 ... witnessing include advancements in extracellular microelectrode arrays and intracellular microelectrodes, research ...
Breaking Medicine Technology: